More

    Updated boosters for elementary school-aged children ‘weeks’ from authorization: FDA vaccine chief

    spot_img

    New boosters for 5- to 11-year-olds are just weeks away from authorization, the vaccine chief at the Food and Drug Administration, Dr. Peter Marks, said Tuesday.

    While primary vaccines are already authorized for children 6 months and older, the FDA has yet to authorize the newly updated booster shots — designed specifically to combat currently circulating omicron subvariants — for the youngest Americans.

    PHOTO: In this May 11, 2021, file photo, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies on Capitol Hill in Washington, D.C.

    In this May 11, 2021, file photo, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies during a Senate Health, Education, Labor, and Pensions hearing to examine an update from Federal officials on efforts to combat COVID-19, on Capitol Hill in Washington, D.C.

    Jim Lo Scalzo, Pool via AP, FILE

    Those boosters, which were authorized at the beginning of the month for everyone 12 and older, will next be authorized for children in the elementary school age range, and then later be authorized for kids under 5.

    “I’m confident that we’re only a matter of weeks away” from authorizing the 5-11 age range, Marks said during an event with the COVID-19 Vaccine Education and Equity Project. Marks said that the youngest age group, kids under 5, was still “a few months away” from authorization.

    “Tailoring a vaccine against the most widely circulating variant is a similar approach used against the influenza virus, and I would not be surprised if this is an approach we see, seasonally, with COVID-19,” said Dr. Alok Patel, a pediatrician at Stanford Children’s Health and an ABC News medical contributor.

    PHOTO: In this July 8, 2022, file photo, a 7-year-old receives a vaccination shot at a COVID vaccination clinic in Pasadena, Calif.

    In this July 8, 2022, file photo, a 7-year-old receives a vaccination shot at a COVID vaccination clinic in Pasadena, Calif.

    Los Angeles Dail/MediaNews Group via Getty Images, FILE

    But kids under 5 were just recently authorized for primary vaccines, Marks said, so many are still in the process of getting their first doses and not yet in need of boosters.

    Fewer than 40% of 5- to 11-year-olds and 10% of younger children 6 months to 4 years old have started their primary COVID-19 vaccination series, according to the American Academy of Pediatrics. Marks urged parents to generally get their kids vaccinated because the updated boosters cannot be given to people who haven’t yet received a primary series.

    “There are a lot of kids ages 5 to 11 out there who haven’t had their primary series, so you can’t get the updated booster until you’ve had the primary series. So it’s a good idea to think about getting your child vaccinated against COVID-19,” Marks said.

    “It’s critical parents not only get their children vaccinated but stay up to date about news on upcoming boosters,” Patel said. “While data and information becomes available regarding the omicron-specific booster for kids, I would encourage parents to make sure their kids have completed their primary vaccine series to prevent any delays.”

    Source link

    Share

    All countries
    696,052,721
    Total confirmed cases
    Updated on October 3, 2023 9:11 am
    Italy
    26,082,645
    Total confirmed cases
    Updated on October 3, 2023 9:11 am
    Spain
    13,914,811
    Total confirmed cases
    Updated on October 3, 2023 9:11 am
    Iran
    7,616,791
    Total confirmed cases
    Updated on October 3, 2023 9:11 am
    Germany
    38,494,789
    Total confirmed cases
    Updated on October 3, 2023 9:11 am

    Latest Updates

    Frequently Asked Questions

    spot_img

    Related Articles

    FDA clears new Covid boosters: 5 things to know

    The Food and Drug Administration earlier this month greenlighted updated Covid boosters from Pfizer...

    New Covid vaccine rollout hampered by canceled appointments, insurance issues

    Some people seeking the newest Covid vaccines are running into high demand, insurance headaches...

    As Covid cases rise, what to know about Paxlovid

    Covid cases and hospitalizations have risen again. Some Americans are anxious about possibly getting...

    Long Covid blood test shows differences in the immune system, research finds

    More than three years into the pandemic, the millions of people who have suffered...